ID

34387

Description

Influence of Probiotics Administration Before Liver Resection in Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02021253

Lien

https://clinicaltrials.gov/show/NCT02021253

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 07/10/2020 07/10/2020 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Liver Fibrosis NCT02021253

Eligibility Liver Fibrosis NCT02021253

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
agreement signed by the patient
Description

ID.1

Type de données

boolean

diagnosis of hcc confirmed
Description

ID.2

Type de données

boolean

diagnosis of liver disease (score f3 or f4) confirmed
Description

ID.3

Type de données

boolean

indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
Description

ID.4

Type de données

boolean

patient operable (no indication against anaesthesiological)
Description

ID.5

Type de données

boolean

resectable tumor lesion (surgical expertise)
Description

ID.6

Type de données

boolean

laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
Description

ID.7

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
Description

ID.8

Type de données

boolean

antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
Description

ID.9

Type de données

boolean

inflammatory bowel disease, which could skew the results expected by taking probiotics results.
Description

ID.10

Type de données

boolean

Similar models

Eligibility Liver Fibrosis NCT02021253

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
agreement signed by the patient
boolean
ID.2
Item
diagnosis of hcc confirmed
boolean
ID.3
Item
diagnosis of liver disease (score f3 or f4) confirmed
boolean
ID.4
Item
indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
boolean
ID.5
Item
patient operable (no indication against anaesthesiological)
boolean
ID.6
Item
resectable tumor lesion (surgical expertise)
boolean
ID.7
Item
laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
boolean
Item Group
C0680251 (UMLS CUI)
ID.8
Item
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
boolean
ID.9
Item
antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
boolean
ID.10
Item
inflammatory bowel disease, which could skew the results expected by taking probiotics results.
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial